Largest pharmaceuticals by total debt

Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.

AbbVie leads the 35 pharmaceuticals ranked by total debt, at R$391.6B, ahead of Pfizer (R$375.9B) and Merck & Co (R$286B). Figures as of 18 Nov 2026, 14:10 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
35
First
AbbVieR$391.6B
Median
R$30.6B
Combined market value
R$29.92T
Countries
10
Not ranked
26no total debt on file

Market values as of .

Largest pharmaceuticals by total debt
#CompanyTotal debt ↓Market capPriceToday1 yearPrice, 30 daysCountry
1AbbVieABBV · Health CareR$391.6BR$3TR$1,698.74 0.59% down 26% up United States
2PfizerPFE · Health CareR$375.9BR$941.4BR$165.16 1.35% down 14% up United States
3Merck & CoMRK · Health CareR$286BR$2.05TR$831.73 0.75% down 51% up United States
4Johnson & JohnsonJNJ · Health CareR$278.1BR$3.89TR$1,616.82 1.36% down 38% up United States
5Bristol-Myers SquibbBMY · Health CareR$261.7BR$727.5BR$355.91 2.51% down 34% up United States
6Eli LillyLLY · Health CareR$246.6BR$7.31TR$8,212.03 1.13% down 35% up United States
7Takeda PharmaceuticalTAK · Health CareR$177.4BR$401.1BR$125.54 0.23% up 54% up Japan
8AstraZenecaAZN · Health CareR$171.8BR$1.64TR$1,057.40 0.95% down 2% up United Kingdom
9NovartisNVS · Health CareR$166.7BR$1.74TR$923.16 0.67% down 25% up Switzerland
10SanofiSNY · Health CareR$120.4BR$662.1BR$275.74 1.78% down 4% down France
11Novo NordiskNVO · Health CareR$112.7BR$1.04TR$236.11 2.16% down 17% down Denmark
12GSKGSK · Health CareR$111.3BR$572.6BR$285.66 2.32% down 6% up United Kingdom
13ViatrisVTRS · Health CareR$83.6BR$136BR$118.64 1.40% down 96% up United States
14Abbott LaboratoriesABT · Health CareR$75BR$1.05TR$607.45 2.55% down 17% down United States
15ZoetisZTS · Health CareR$52.5BR$196.8BR$484.29 1.08% down 29% down United States
16Royalty PharmaRPRX · Health CareR$51.9BR$229.1BR$398.43 0.23% up 78% up United States
17Jazz PharmaceuticalsJAZZ · Health CareR$31.1BR$89.6BR$1,396.43 0.39% up 37% up Ireland
18GenmabGMAB · Health CareR$30.6BR$185.9BR$301.44 0.76% up 70% up Denmark
19Elanco Animal HealthELAN · Health CareR$23.3BR$75BR$149.96 2.12% down 20% up United States
20Amneal PharmaceuticalsAMRX · Health CareR$14.9BR$42.7BR$122.52 0.52% down 83% up United States
21BridgeBio PharmaBBIO · Health CareR$11.6BR$86.8BR$445.54 0.72% down 17% up United States
22Regeneron PharmaceuticalsREGN · Health CareR$11.5BR$574.8BR$5,556.25 0.56% up 36% up United States
23Ionis PharmaceuticalsIONS · Health CareR$10.5BR$26BR$156.40 3.75% down 64% down United States
24BeOne MedicinesONC · Health CareR$6BR$273.9BR$2,397.45 0.48% up 17% up Switzerland
25Ascendis PharmaASND · Health CareR$4.6BR$103.2BR$1,573.25 0.20% down 28% up Denmark
26InsmedINSM · Health CareR$3.2BR$155.1BR$706.95 0.83% down 40% down United States
27Madrigal PharmaceuticalsMDGL · Health CareR$2BR$56.9BR$2,448.09 0.46% down 24% down United States
28Legend BiotechLEGN · Health CareR$1.9BR$18.1BR$93.46 0.75% up 42% down United States
29CytokineticsCYTK · Health CareR$1.7BR$41.7BR$299.64 2.86% down 20% down United States
30TG TherapeuticsTGTX · Health CareR$1.4BR$55BR$363.80 0.08% down 107% up United States
31Cogent BiosciencesCOGT · Health CareR$1.3BR$28.1BR$161.57 1.49% up 20% down United States
32Dr. Reddy's LaboratoriesRDY · Health CareR$1.1BR$71.5BR$85.80 0.61% up 5% up India
33Axsome TherapeuticsAXSM · Health CareR$1.1BR$41.5BR$788.69 0.77% down 7% down United States
34Rhythm PharmaceuticalsRYTM · Health CareR$627.6MR$46.9BR$676.49 8.49% up 13% up United States
35Definium TherapeuticsDFTX · Health CareR$235.4MR$23.3BR$170.44 2.59% down 169% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total debt is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Total debt is assembled from each company's debt lines and is the least complete of these figures: some companies tag part of their borrowings in ways it misses. Sums are converted from US dollars at today's exchange rate (1 USD = 5.8013 BRL). 26 companies have no total debt on file and are not ranked here.

Questions and answers

Which pharmaceuticals rank first by total debt?

AbbVie (R$391.6B), Pfizer (R$375.9B) and Merck & Co (R$286B) are the top three of the 35 pharmaceuticals ranked by total debt as of 18 Nov 2026, 14:10 UTC.

How many pharmaceuticals are in this ranking?

35 are ranked by total debt. 26 more have no total debt on file and are left out rather than ranked at zero.

What are these pharmaceuticals worth together?

The 35 pharmaceuticals ranked by total debt have a combined market value of R$29.92T as of 18 Nov 2026, 14:10 UTC.

What does ranking by total debt measure?

Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.

Cite this page

Funkfolio, “Largest pharmaceuticals by total debt”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=total-debt

Underlying data: Yahoo Finance; SEC EDGAR.